StairMed Bags $72.5M from Alibaba, Tencent

🔑 Enhanced Key Takeaways

• •Funding round led by Alibaba with participation from SDIC Unity Capital and existing investors like FountainBridge Capital, OrbiMed, Qiming Venture Partners, and others, bringing StairMed's total funding to RMB 1.1 billion (USD 159.9 million) over the past year[1].
• •Unveiled second-generation WRS02 high-throughput wireless invasive BCI system in December with 256 electrode channels, supporting motor control restoration and potential language reconstruction[1].
• •Completed clinical implantation of 256-channel BCI using self-developed surgical robot by early 2026, validating brain-controlled interaction functions[1].
• •Plans multicenter registration clinical trials later in 2026 targeting 40 patients amid China's policy support for BCI as billable medical services[1].

🛠️ Technical Deep Dive

• •WRS02 is a second-generation high-throughput wireless invasive BCI system featuring 256 electrode channels[1].
• •Designed for restoring motor control and exploring language reconstruction applications[1].
• •Utilizes a self-developed surgical robot for clinical implantation, enabling validation of brain-controlled interaction functions[1].

🔮 Future ImplicationsAI analysis grounded in cited sources

⏳ Timeline